Clinical trial
A Study to Evaluate the Performance, Usability, and Result Interpretation of INSTI® HIV Self-Test When Performed by Observed Intended Users in the US
NCT06368453 is registered in ClinicalTrials.gov with bioLytical Laboratories as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Evaluate the Performance, Usability, and Result Interpretation of INSTI® HIV Self-Test When Performed by Observed Intended Users in the US
- Lead sponsor
- bioLytical Laboratories
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 2, 2024
- Completion date
- January 8, 2025
- Enrollment
- 1,728 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
human immunodeficiency virus i infection, human immunodeficiency virus ii infection